Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-26 Purchase | 2024-03-27 8:27 pm | Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer | 100,000 | $3.75 | $375,000 | 354,958 (Indirect) | View |
2023-12-13 Purchase | 2023-12-13 4:49 pm | Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer | 20,400 | $2.1693 | $44,254 | 254,958 (Indirect) | View |
2023-03-07 Purchase | 2023-03-08 5:24 pm | Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer | 196,362 | $1.05 | $206,180 | 274,085 (Indirect Direct) | View |
2022-08-16 Purchase(A) | 2023-03-08 4:58 pm | Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer | 37,685 | $0.97 | $36,554 | 77,723 (Indirect Direct) | View |
2022-08-16 Purchase | 2022-08-17 4:49 pm | Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer | 36,215 | $0.97 | $35,129 | 76,253 (Indirect Direct) | View |
2021-11-24 Purchase | 2021-11-29 4:19 pm | CareDx Inc. | CDNA | Dhingra Ankur Chief Financial Officer | 5,000 | $42.34 | $211,694 | 19,500 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-06 Option Award | 2024-05-08 6:17 pm | N/A 2027-01-03 | ILLUMINA INC. | ILMN | Dhingra Ankur SVP, Chief Financial Officer | 29,418 | $0 | 29,418 (Direct) | View |
Ownership | 2022-06-02 5:38 pm | N/A N/A | Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer | 0 | $0 | 40,038 (Direct) | View |
2022-05-31 Option Award | 2022-06-02 5:29 pm | N/A 2032-05-31 | Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer | 600,000 | $0 | 600,000 (Direct) | View |
2022-03-25 Tax Withholding | 2022-03-28 7:31 pm | N/A N/A | CareDx Inc. | CDNA | Dhingra Ankur Chief Financial Officer | 1,254 | $37.9 | 38,146 (Direct) | View |
2022-02-02 Option Award | 2022-02-04 5:48 pm | N/A 2023-02-02 | CareDx Inc. | CDNA | Dhingra Ankur Chief Financial Officer | 54,800 | $0 | 74,300 (Direct) | View |
2021-03-25 Option Award | 2021-03-25 5:56 pm | N/A 2031-03-25 | CareDx Inc. | CDNA | Dhingra Ankur Chief Financial Officer | 44,500 | $0 | 44,500 (Direct) | View |